Thromb Haemost 1975; 33(03): 564-572
DOI: 10.1055/s-0038-1647850
Original Article
Schattauer GmbH

Further Investigations on Antithrombin III in the Plasmas of Patients with the Abnormality of ‘Antithrombin III Budapest’

Géza Sas*
1   South East Scotland Regional Blood Transfusion Centre, Royal Infirmary, Edinburgh EH3 9HB
,
Duncan S Pepper
1   South East Scotland Regional Blood Transfusion Centre, Royal Infirmary, Edinburgh EH3 9HB
,
John D Cash
1   South East Scotland Regional Blood Transfusion Centre, Royal Infirmary, Edinburgh EH3 9HB
› Author Affiliations
Further Information

Publication History

Received 12 January 1975

Accepted 02 March 1975

Publication Date:
02 July 2018 (online)

Summary

Antithrombin III (AT-III) was studied in a thrombophilic family with an abnormal AT-III molecule (antithrombin III Budapest) using a modified crossed Immunoelectrophoresis technique, gel filtration, ‘rocket’ Immunoelectrophoresis and a heparin cofactor assay.

When plain agarose was applied in the first phase of the crossed Immunoelectrophoresis, the normal and the pathological AT-III revealed identical electrophoretic mobility. However, when heparin was mixed with agarose in the first phase of electrophoresis, the propositus’ plasma displayed a different AT-III pattern from normal plasma. His plasma contained the first component of the normal plasma (Immune Antithrombin III1, IAT-III1) in a concentration of only 5% of normal, and a protein in high concentration which although immunoreactive to AT-III antisera, had an electrophoretic mobility similar (but not identical) to that of IAT-III2. This ab-normal protein had no heparin cofactor activity and a molecular size greater than normal plasma AT-III. Unlike normal AT-III, the addition of heparin did not change the molecular size of the pathologic AT-III molecule significantly.

The abnormal protein was present in lower concentrations in the patient’s children and at the time of study they had no clinical or laboratory evidence of intravascular coagulation.

* Present Address: Postgraduate Medical School, First Department of Medicine, Budapest.


 
  • References

  • 1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 1965; 13: 516
  • 2 Laurell C. B. Antigen-antibody crossed electrophoresis. Analytical Biochemistry 1965; 10: 358
  • 3 Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 1966; 15: 45
  • 4 Marciniak E, Farley C. H, Desimone P. A. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219
  • 5 Sas G, Blasko G, Banhegyi D, Jako J, Palos L. A. Abnormal antithrombin III (Antithrombin III ’Budapest’) as a cause of a familial thrombophilia. Thrombosis et Diathesis Haemorrhagica 1974; 32: 105
  • 6 Sas G, Pepper D. S, Cash J. D. Plasma and serum antithrombin III. Differentiation by crossed Immunoelectrophoresis. Thrombosis Research 1975; 6: 1
  • 7 Sas G, Pepper D. S, Cash J. D. Investigation on antithrombin III in normal plasma and serum. British Journal of Haematology(In Press). 1975
  • 8 Van der Meer J, Stoepman-Van Dalen E. A, Jansen J. M. S. Antithrombin III deficiency in a Dutch family. In IVth International Congress on Thrombosis and Haemostasis, Vienna . 1973: 226 Abstracts